Anticancer activity of FTY720: Phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D
- 8 August 2008
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 266 (2), 203-208
- https://doi.org/10.1016/j.canlet.2008.02.052
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaBlood, 2008
- FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemiaJCI Insight, 2007
- The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1‐phosphate receptor 1Journal of Cellular Biochemistry, 2007
- Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and MetastasisPublished by Elsevier BV ,2006
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesProceedings of the National Academy of Sciences of the United States of America, 2006
- Fluorogenic Phospholipid Substrate to Detect Lysophospholipase D/Autotaxin ActivityOrganic Letters, 2006
- The ins and outs of lysophosphatidic acid signalingBioEssays, 2004
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Nucleotide Binding to Autotaxin: Crosslinking of Bound Substrate Followed by lysC Digestion Identifies Two Labeled PeptidesBiochemical and Biophysical Research Communications, 1997